Master Degree in Biomedical Sciences to work at Cancer Research Center Salamanca

29 Feb 2024
Job Information

Organisation/Company

Fundación Investigación del Cáncer Universidad de Salamanca

Research Field

Biological sciences

Researcher Profile

First Stage Researcher (R1)

Country

Spain

Application Deadline

15 Mar 2024 - 00:00 (Europe/Madrid)

Type of Contract

Temporary

Job Status

Part-time

Hours Per Week

20

Offer Starting Date

2 Mar 2024

Is the job funded through the EU Research Framework Programme?

Not funded by an EU programme

Reference Number

24-5-RGSTS

Is the Job related to staff position within a Research Infrastructure?

No

Offer Description

• Required Education Level: Master Degree in Biomedical Sciences.
• Skills/Qualifications: Knowledge inHematology, Acute Myeloblastic Leukemia (AML); Minimal residual disease (MRD). DNA/RNA extraction. Study of molecular alterations. Molecular techniques: Sanger sequencing, RT-PCR, digital PCR and/or massive sequencing. Management of databases, bibliographic searches (Pubmed, others), etc.
• Specific Requirements: Development of research projects in monoclonal gammopathies. The candidate will be trained The candidate will be trained in:
  • Molecular techniques for diagnosing and monitoring multiple myeloma, including Sanger mutations, allelic discrimination and next-generation sequencing (NGS), as well as NGS EMR analysis.
  • Specifically, he/she will be trained in the development of the study of the genes with the most relevant mutations in myeloma and other gammopathies using NGS and digital PCR,
  • Studies of translocations and copy number variations, including studies with single-cell sequencing.
  • Mutation analysis by capillary electrophoresis,
  • Computer analysis and interpretation of data from the different techniques.
  • Management of databases and statistical programs
• Required Languages: Spanish, English
• Required Research Experience (years of research experience):

12 months in biological management of AML.

 

TYPE OF CONTRACT : Temporary

JOB STATUS: Half-time

HOURS PER WEEK:  20

SALARY:   II FICUS Collective Agreement

ENVISAGED JOB STARTING DATE:   April 2024

OFFER STARTING DATE: March 1, 2024

REFERENCE NUMBER: 24-4-RGSTS

 

Apply for the job position  REF: 24-5-RGSTS in  https://www.cicancer.org , Job Offers.

 

DEADLINE:  March 15, 2024.

 

 

Requirements

Research Field

Biological sciences

Education Level

Master Degree or equivalent

Skills/Qualifications

• Knowledge inHematology, Acute Myeloblastic Leukemia (AML); Minimal residual disease (MRD). DNA/RNA extraction. Study of molecular alterations. Molecular techniques: Sanger sequencing, RT-PCR, digital PCR and/or massive sequencing. Management of databases, bibliographic searches (Pubmed, others), etc.

Specific Requirements

• Development of research projects in monoclonal gammopathies. The candidate will be trained The candidate will be trained in:
  • Molecular techniques for diagnosing and monitoring multiple myeloma, including Sanger mutations, allelic discrimination and next-generation sequencing (NGS), as well as NGS EMR analysis.
  • Specifically, he/she will be trained in the development of the study of the genes with the most relevant mutations in myeloma and other gammopathies using NGS and digital PCR,
  • Studies of translocations and copy number variations, including studies with single-cell sequencing.
  • Mutation analysis by capillary electrophoresis,
  • Computer analysis and interpretation of data from the different techniques.
  • Management of databases and statistical programs

Languages

ENGLISH

Research Field

Biological sciences

Years of Research Experience

1 - 4

Additional Information
Benefits

• Benefits

• Working conditions:
  • Full time temporal contract with salary according to both experience and labor-approved stipend scales.
  • Measures to reconcile work and family life (maternity and paternity leave, flexible schedule working hours, teleworking, 22 working days of paid holidays, 5 leave days for personal matters, among others).
• A rich scientific environment that fosters interdisciplinary and high-quality research in cancer and its common morbidities.
• Opportunities for professional development: wide program of scientific seminars by foreign and Spanish speakers, internal seminars, mobility grants, professional development orientation, and mentoring programs for master, Ph.D. and postdoctoral researchers.
•  

Eligibility criteria

 

FICUS ensures the utmost rigor in the application of the principles of equality, merit and ability in public employment and current rules on data protection. In line with this, FICUS follows the principles set forth by both the Code of Conduct for the Recruitment of Researchers of the European Commission and the Open, Transparent and Merit- based Recruitment of Researchers (OTM-R) policy.

FICUS is a center that advocates equal job opportunities for men and women, foreign and national, and promote nondiscrimination by reason of age, race or ethnic origin, religion or belief, sexual orientation, language, disability, political orientation or social or economic conditions.

Selection process

For more details see the official call (in Spanish)   https://www.cicancer.org/jobs- offers-public-procurement/job-offers-ofertas-de-empleo/open-positions

Please send the application form, your CV, a cover letter explaining your interest in the project and reference letter from recent to: https://www.cicancer.org/jobs-offers-public-procurement/job-offers-ofer…

 

Shortlisted applicants might be invited for a Skype or personal interview by the Recruitment Committee.

 

We will interview at least the 3 candidates with the highest score, if 3 or more candidates will score more than 12.5 points (PHASE I). The candidate that will be hired will be the one with the highest score selected among all the candidates with a global score.

 

Additional comments

 

Scientific activities will be carried out at the Centro de Investigación del Cáncer / Cancer Research Center (CIC) that is located in the city of Salamanca (Spain).

The CIC is one of the international-leading research centers in Spain in terms of scientific output, carrying out innovative biomedical research related to cancer and other high-incidence diseases at the basic, translational, and clinical level (www.cicancer.org/en ). It houses 27 research laboratories, ten technical units, and ≈220 research and administration staff. The CIC is located in a rather active biomedical campus that encompasses a University Hospital with an associated Health Research Institute, two additional USAL-ran Research Institutes (Neurosciences and Functional Genomics), all the Biomedical schools (Medicine, Pharmacology, Biology, Biotechnology), and an adjacent Scientific/Industrial Campus where ten start-up companies have been established. The CIC trains, in close association with the USAL, master, graduate, and post-doctoral students in average per year. Given its close connection with patient-associated initiatives, the CIC has been recognized as a Health Centre by the Castilla-León Health System (SACYL; Reg. #5-14-0001). With this accreditation, the CIC can carry out Hospital-like tasks (diagnostic, Hospital-associated clinical trials). Many of the CIC research groups have stable collaborations with biopharmaceutical companies.

In addition to standard administration, human resources and maintenance units, the CIC has a number of specialized technical facilities for Diagnostic Molecular Pathology, Genomics & Proteomics, Bioinformatics, Flow Cytometry, Advanced Microscopy, Structural Biology and Scientific Communication. It also has an adjacent Animal Experimentation and Transgenic Facility. All these facilities are fully certified by Bureau Veritas Bureau Veritas (ISO9001 and ISO 45001), which allow them to carry out fully licensed technical services. Unlike the case of most facilities in academic centers, the CIC technical units have been developed with the goal of providing service to both indoor and outdoor scientists, academic and healthcare institutions, and the biopharmaceutical industry. In addition, these units have as one of their goals to help disseminating new technologies, either by organizing courses or by participating in nationwide technological platforms (i.e., the Spanish Institute of Proteomics-ProteoRed initiative).

Website for additional job details

https://www.cicancer.org

Work Location(s)

Number of offers available

1

Company/Institute

Fundación Investigación del Cáncer Universidad de Salamanca

Country

Spain

Geofield

Where to apply

Website

https://www.cicancer.org

Contact

State/Province

Salamanca

City

Salamanca

Website

http://www.cicancer.org/es

Street

Campus Miguel de Unamuno

Postal Code

37007

E-Mail

[email protected]

STATUS: EXPIRED